The global Tonic-Clonic Seizure Market is poised to experience significant growth in revenue due to the increasing prevalence of epilepsy and other neurological disorders. According to the World Health Organization (WHO), epilepsy accounts for more than 0.5% of the disease burden worldwide, affecting approximately 4 to 10 out of every 1,000 individuals with active epilepsy or ongoing seizures requiring treatment.

https://www.reportsanddata.com..../report-detail/tonic